Your session is about to expire
What is Pediapred
PrednisoloneThe Generic name of this drug
Treatment SummaryPrednisolone phosphate is a steroid drug used to reduce inflammation, suppress the immune system, and prevent tumor growth. It was approved by the FDA in 1973 and is similar to cortisol.
Prednisoloneis the brand name
Pediapred Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Prednisolone
Prednisolone
1974
37
Approved as Treatment by the FDA
Prednisolone, otherwise known as Prednisolone, is approved by the FDA for 2 uses including Ulcerative Colitis and Pneumocystis Jirovecii Pneumonia .Ulcerative Colitis
Helps manage Ulcerative Colitis
Pneumocystis Jirovecii Pneumonia
Used in combination with Dapsone to help manage Pneumocystis Jirovecii Pneumonia
Effectiveness
How Pediapred Affects PatientsPrednisolone is a corticosteroid drug that works by blocking pro-inflammatory signals and encouraging anti-inflammatory signals. Its effects do not last very long, as it has a half-life of 2-4 hours. It has a wide range of effective dosages, and much more than what the body would normally produce. Taking this drug carries risks, including weakening the body's natural ability to fight infections and suppressing hormones produced by the hypothalamus, pituitary gland, and adrenal glands.
How Pediapred works in the bodyCorticosteroids help reduce inflammation. They work by binding to a receptor in the body that changes the activity of certain genes. Corticosteroids stop white blood cells from accumulating at sites of inflammation, and also stop molecules that cause inflammation from forming. Lower doses of corticosteroids act as an anti-inflammatory, while higher doses reduce the body's immune response. When high doses of corticosteroids are taken for a long period of time, they can cause an imbalance of sodium and potassium levels in the body.
When to interrupt dosage
The recommended dosage of Pediapred is contingent upon the certified situation, including Uveitis, Ocular Inflammation and Ophthalmia, Sympathetic. The amount of dosage fluctuates in accordance with the method of delivery indicated in the table below.Condition
Dosage
Administration
Secondary thrombocytopenia
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Congenital adrenal hyperplasia
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Aspiration Pneumonitis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Communicable Diseases
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Epicondylitis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Perennial Allergic Rhinitis (PAR)
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Brain
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Skin
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Corneal injuries
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Pulmonary Fibrosis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Chorioretinitis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Multiple Sclerosis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Fissure;Anal
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
exfoliative erythroderma
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Superficial punctate keratitis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Organ Transplantation
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Optic Neuritis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Psoriatic Arthritis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Chronic Obstructive Airway Disease
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Choroiditis
, 15.0 mg/mL, 25.0 mg/mL, 10.0 mg, 30.0 mg, 15.0 mg, 10.0 mg/mL, 5.0 mg/mL, 5.0 mg/mg, 20.0 mg/mL, 1.2 mg/mL, 5.0 mg, 1.0 mg, 25.0 mg, 20.0 mg, 0.004 mg/mg, 16.7 mg/mL
, Ophthalmic, Ointment - Ophthalmic, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Syrup - Oral, Syrup, Solution / drops - Ophthalmic, Tablet, Tablet - Oral, Solution - Ophthalmic, Suspension - Oral, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Liquid, Liquid - Oral, Ophthalmic; Topical, Topical, Ointment, Ointment - Topical
Warnings
Pediapred ContraindicationsCondition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Prednisolone may interact with Pulse Frequency
Common Pediapred Drug Interactions
Drug Name
Risk Level
Description
2-Methoxyethanol
Major
The risk or severity of adverse effects can be increased when Prednisolone is combined with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Prednisolone is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abatacept
Major
The risk or severity of adverse effects can be increased when Prednisolone is combined with Abatacept.
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Prednisolone.
Abetimus
Major
The risk or severity of adverse effects can be increased when Prednisolone is combined with Abetimus.
Pediapred Toxicity & Overdose RiskNot much is known about overdosing on prednisone, but those who take too much for a long period of time may show signs such as confusion, a round face, extra fat deposits, and water retention. If someone has taken too much prednisone orally, they should be given their stomach pumped or made to vomit. If someone has been taking too much prednisone for a long time, their dosage should be lowered or taken every other day.
Pediapred Novel Uses: Which Conditions Have a Clinical Trial Featuring Pediapred?
115 active clinical trials are currently in progress to examine the potential of Pediapred in alleviating Ocular Inflammation, Uveitis, Sympathetic Ophthalmia and other conditions.Condition
Clinical Trials
Trial Phases
Osteoarthritis (OA)
0 Actively Recruiting
Eczema
0 Actively Recruiting
Allergic Contact Dermatitis
2 Actively Recruiting
Phase 2, Phase 3, Not Applicable
Dermatitis
0 Actively Recruiting
Dermatomyositis (DM)
1 Actively Recruiting
Phase 1
Bronchiolitis
0 Actively Recruiting
Multiple Sclerosis
0 Actively Recruiting
Pulmonary Tuberculosis (TB)
0 Actively Recruiting
Bacterial Infections
0 Actively Recruiting
Pruritus Ani
0 Actively Recruiting
Sarcoidosis
0 Actively Recruiting
varicella-zoster virus acute retinal necrosis
0 Actively Recruiting
Rosacea
8 Actively Recruiting
Not Applicable, Early Phase 1, Phase 2, Phase 4
Thyroiditis
0 Actively Recruiting
Rheumatoid Arthritis, Juvenile
4 Actively Recruiting
Not Applicable, Phase 3
Drug Allergy
0 Actively Recruiting
Eye
0 Actively Recruiting
Tuberculous Meningitis
0 Actively Recruiting
Eosinophilic Pneumonia
0 Actively Recruiting
Inflammatory Reaction caused by susceptible Bacterial Infections
0 Actively Recruiting
Pediapred Reviews: What are patients saying about Pediapred?
4Patient Review
2/12/2008 My 3 year old takes this for asthma/wheezing/breathing problems. The only problem I've had with it is that is makes him very cranky & grouchy, more so than a 3 year old would usually be.
4Patient Review
12/14/2008 This medicine is great! My 6 year old daughter uses this to treat her asthma attacks and I have never found anything else that works this well. The only complaint that I have is it tastes horrible. Other than it making her hungry and a little on the touchy side (cries at the littlest things) this medicine is wonderful.
3.3Patient Review
12/18/2009 While this medicine did reduce my 1 year old's slight wheezing, it also gave him a terrible case of thrush and a yeast infection that was even more painful, and long lasting.
Patient Q&A Section about pediapred
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is Pediapred liquid?
"PEDIAPRED® Oral Solution is a colorless to light straw-colored, raspberry flavored solution. Each 5 mL (teaspoonful) of PEDIAPRED® Oral Solution contains 6.7 mg PEDIAPRED® (5 mg prednisolone base) in a palatable, aqueous vehicle."
Answered by AI
What is prednisolone prescribed for?
"Prednisolone is a medicine that is used to treat various health conditions. These health conditions include allergies, blood disorders, skin diseases, inflammation, infections, and certain cancers. Prednisolone can also help to prevent organ rejection after a transplant. This medicine works by reducing swelling (inflammation). Prednisolone can also help to calm down your immune system."
Answered by AI
How long does it take for Pediapred to work?
"It usually takes 3 to 10 days to treat this, although it can take longer."
Answered by AI
What is Pediapred used for?
"This drug is used to treat a variety of conditions, including arthritis, blood disorders, immune system disorders, skin and eye conditions, breathing problems, cancer, and severe allergies. It works by decreasing the immune system's response to diseases, which decreases symptoms such as pain, swelling, and allergic reactions."
Answered by AI